© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
Market Access
Product Launch Strategies: Adapting Approaches in 2020 and Beyond
June 01, 2020
Pharmaceutical Executive
With new access levers emerging, positioning products will require a shift form the traditional launch playbook.
Drive for COVID-19 Therapies Raises Patent and Pricing Issues
May 16, 2020
Pharmaceutical Executive
Proposals around the globe seek to ensure access to any promising treatments.
Market Access: From Being to Becoming
March 11, 2020
Pharmaceutical Executive
Examining the key learnings from BCG’s 2019 benchmark study-and the capabilities uncovered that will be critical to future performance.
Access-Based Commercial (ABC) Strategy for Drug Commercialization
March 06, 2020
Wolfram Lux and Simon Seiter discuss the implications of Strategic Market Access on work and processes, and its role in product planning and drug development success.
A Passion for Access: Banks Bourne, Tanner Pharma Group
March 06, 2020
Banks Bourne of Tanner Pharma Group talks about the organization's role in delivering access initiatives for products not commercially available in many parts of the world.
Is the Tail Wagging the Dog in Drug Market Entry?
January 13, 2020
Pharmaceutical Executive
Three product launch trends driven by emerging biopharma.
Market Access: Employers as Barriers to Value
December 18, 2019
Pharmaceutical Executive
Renewed education efforts by employers, however, are slowly helping them take back decision-making reins in their engagements with pharma.
Lundbeck's Taj Bhardwaj: Market Access and Mental Health
December 17, 2019
Pharmaceutical Executive
Lundbeck executive Taj Bhardwaj talks about the differing mindsets necessary to lead local and global-level market access strategy in pharma-and how his current company is committed to stay in the fight to advance new treatments and break down stigmas in mental health.
The Route to Market Access in Europe
December 17, 2019
Pharmaceutical Executive
Exploring the roadmap for US-based, R&D-focused biopharma companies seeking to successfully penetrate product markets and reach patients in Europe.
A Multi-Stakeholder Perspective On Assessing Drug Value
December 17, 2019
Pharmaceutical Executive
Industry working group identifies the value characteristics that may, collectively, become part of a shared approach to valuing pharmaceutical treatments.